Laboratory Developed Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Laboratory Developed Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


As of 2024, the global laboratory developed test market is estimated to be valued at USD 8.4 billion. It is projected to reach USD 12.3 billion by 2031, reflecting a compound annual growth rate (CAGR) of 5.5% over the forecast period. This growth is primarily fueled by the rising demand for personalized diagnostic solutions and advancements in clinical biochemistry tests.

Rising Demand for Clinical Biochemistry Tests

Clinical biochemistry tests are anticipated to hold a significant market share by 2031. These tests are essential for diagnosing and monitoring various conditions, including oncology, genetics, infections, and autoimmune diseases. Laboratory developed tests offer numerous benefits, such as improved quality of life, monitoring pre-existing conditions, and providing valuable insights into one’s genetic makeup.

Market Dynamics and Trends

Several factors contribute to the growth of the laboratory developed test market, including increasing healthcare expenditure on chronic and genetic conditions, rising cancer cases, and the need for early detection and monitoring of diseases.

Key Market Insights

The U.S. accounted for a dominant share of the North America laboratory developed test market, primarily due to the high prevalence of obesity and related chronic conditions. Germany is expected to see significant growth owing to stringent regulatory approvals and increased product offerings. Meanwhile, China is emerging as a lucrative market due to rising diabetes incidence and advancements in human microbiota diagnostics.

Innovations and Product Launches Driving Market Growth

Recent product launches and innovations have further fueled market growth. For instance, Illumina, Inc. released TruSightTM Oncology (TSO) Comprehensive, a single test examining numerous tumor genes and biomarkers. Similarly, QIAGEN N.V. secured a contract from the U.S. government to expand its production capacity for PCR testing systems.

Challenges and Regulatory Analysis

Despite the positive outlook, the market faces challenges such as product recalls and stringent regulatory controls. The Clinical Laboratory Improvement Amendments (CLIA) program and the FDA govern laboratories performing patient sample tests to ensure accuracy and consistency. Recent changes to FDA policies emphasize clear performance thresholds for specificity and sensitivity, impacting the market dynamics.

Strategic Collaborations and Market Expansion

Key players in the market are actively engaging in strategic collaborations, acquisitions, and partnerships to expand their product portfolios and increase market penetration. For instance, Roche launched a high-throughput SARS-CoV-2 antigen test, while Illumina, Inc. partnered with several genomics corporations to build innovative startups.

Opportunities Ahead

Manufacturers of laboratory developed tests are poised to capitalize on lucrative prospects by investing in research and development to diversify their product offerings. The rising adoption of LDTs among patients with chronic conditions and genetic disorders is expected to drive market growth over the coming years.

Country-wise Insights

The United States continues to be a prominent market due to the high prevalence of obesity and chronic conditions. Germany is witnessing a rise in product approvals compliant with stringent regulations, enhancing the adoption of laboratory developed tests. China, with its increasing diabetes incidence and ongoing R&D efforts, is also emerging as a key market for laboratory developed testing services.

Category-wise Insights

Clinical biochemistry tests are crucial for examining body fluids and tracking disease management, making them the preferred choice for patients seeking basic health assessments. Oncology applications of laboratory developed tests underscore the importance of these tests in cancer diagnosis and therapy monitoring.

Key Market Players Include:

Roche

Adaptive Biotechnologies Corporation

Quest Diagnostics

Illumina

Qiagen

Eurofins

Guardant Health

Biotheranostics

Rosetta Genomics

Biodesix

23andme, Inc.

Admera Health

Ambry Genetics Corp.

Bruker Corporation

Epic Sciences, Inc.

SCIEX Pte Ltd.

Opko Health, Inc./Opko Diagnostics

Global Laboratory Developed Test Market Segmentation:

By Test Type:

Clinical Biochemistry

Critical Care

Haematology

Immunology

Microbiology

Molecular Diagnostics

Others

By Application:

Oncology

Genetics

Infectious Diseases

Autoimmune Disorders

Neurology

By End User:

Hospital Laboratories

Specialty Diagnostics Centers

Clinical Research Organizations

Research Institutes

By Region:

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East & Africa

Please note: Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global Laboratory Developed Test Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Laboratory Developed Test Market Outlook, 2019 - 2031
3.1. Global Laboratory Developed Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2031
3.1.1. Key Highlights
3.1.1.1. Clinical Biochemistry
3.1.1.2. Critical Care
3.1.1.3. Haematology
3.1.1.4. Immunology
3.1.1.5. Microbiology
3.1.1.6. Molecular Diagnostics
3.1.1.7. Others
3.2. Global Laboratory Developed Test Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
3.2.1. Key Highlights
3.2.1.1. Oncology
3.2.1.2. Genetics
3.2.1.3. Infectious Diseases
3.2.1.4. Autoimmune Disorders
3.2.1.5. Neurology
3.3. Global Laboratory Developed Test Market Outlook, by End Use, Value (US$ Bn), 2019 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospital Laboratories
3.3.1.2. Specialty Diagnostics Centers
3.3.1.3. Clinical Research Organizations
3.3.1.4. Research Institutes
3.4. Global Laboratory Developed Test Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Laboratory Developed Test Market Outlook, 2019 - 2031
4.1. North America Laboratory Developed Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Clinical Biochemistry
4.1.1.2. Critical Care
4.1.1.3. Haematology
4.1.1.4. Immunology
4.1.1.5. Microbiology
4.1.1.6. Molecular Diagnostics
4.1.1.7. Others
4.2. North America Laboratory Developed Test Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Oncology
4.2.1.2. Genetics
4.2.1.3. Infectious Diseases
4.2.1.4. Autoimmune Disorders
4.2.1.5. Neurology
4.3. North America Laboratory Developed Test Market Outlook, by End Use, Value (US$ Bn), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospital Laboratories
4.3.1.2. Specialty Diagnostics Centers
4.3.1.3. Clinical Research Organizations
4.3.1.4. Research Institutes
4.3.2. Market Attractiveness Analysis
4.4. North America Laboratory Developed Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
4.4.1.2. U.S. Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
4.4.1.3. U.S. Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
4.4.1.4. Canada Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
4.4.1.5. Canada Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
4.4.1.6. Canada Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
4.4.2. Market Attractiveness Analysis
5. Europe Laboratory Developed Test Market Outlook, 2019 - 2031
5.1. Europe Laboratory Developed Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2031
5.1.1. Key Highlights
5.1.1.1. Clinical Biochemistry
5.1.1.2. Critical Care
5.1.1.3. Haematology
5.1.1.4. Immunology
5.1.1.5. Microbiology
5.1.1.6. Molecular Diagnostics
5.1.1.7. Others
5.2. Europe Laboratory Developed Test Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
5.2.1. Key Highlights
5.2.1.1. Oncology
5.2.1.2. Genetics
5.2.1.3. Infectious Diseases
5.2.1.4. Autoimmune Disorders
5.2.1.5. Neurology
5.3. Europe Laboratory Developed Test Market Outlook, by End Use, Value (US$ Bn), 2019 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospital Laboratories
5.3.1.2. Specialty Diagnostics Centers
5.3.1.3. Clinical Research Organizations
5.3.1.4. Research Institutes
5.3.2. Market Attractiveness Analysis
5.4. Europe Laboratory Developed Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
5.4.1.2. Germany Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
5.4.1.3. Germany Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
5.4.1.4. U.K. Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
5.4.1.5. U.K. Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
5.4.1.6. U.K. Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
5.4.1.7. France Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
5.4.1.8. France Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
5.4.1.9. France Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
5.4.1.10. Italy Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
5.4.1.11. Italy Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
5.4.1.12. Italy Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
5.4.1.13. Turkey Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
5.4.1.14. Turkey Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
5.4.1.15. Turkey Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
5.4.1.16. Russia Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
5.4.1.17. Russia Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
5.4.1.18. Russia Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
5.4.1.19. Rest of Europe Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
5.4.1.20. Rest of Europe Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
5.4.1.21. Rest of Europe Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
5.4.2. Market Attractiveness Analysis
6. Asia Pacific Laboratory Developed Test Market Outlook, 2019 - 2031
6.1. Asia Pacific Laboratory Developed Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2031
6.1.1. Key Highlights
6.1.1.1. Clinical Biochemistry
6.1.1.2. Critical Care
6.1.1.3. Haematology
6.1.1.4. Immunology
6.1.1.5. Microbiology
6.1.1.6. Molecular Diagnostics
6.1.1.7. Others
6.2. Asia Pacific Laboratory Developed Test Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
6.2.1. Key Highlights
6.2.1.1. Oncology
6.2.1.2. Genetics
6.2.1.3. Infectious Diseases
6.2.1.4. Autoimmune Disorders
6.2.1.5. Neurology
6.3. Asia Pacific Laboratory Developed Test Market Outlook, by End Use, Value (US$ Bn), 2019 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospital Laboratories
6.3.1.2. Specialty Diagnostics Centers
6.3.1.3. Clinical Research Organizations
6.3.1.4. Research Institutes
6.3.2. Market Attractiveness Analysis
6.4. Asia Pacific Laboratory Developed Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
6.4.1. Key Highlights
6.4.1.1. China Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
6.4.1.2. China Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
6.4.1.3. China Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
6.4.1.4. Japan Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
6.4.1.5. Japan Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
6.4.1.6. Japan Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
6.4.1.7. South Korea Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
6.4.1.8. South Korea Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
6.4.1.9. South Korea Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
6.4.1.10. India Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
6.4.1.11. India Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
6.4.1.12. India Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
6.4.1.13. Southeast Asia Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
6.4.1.14. Southeast Asia Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
6.4.1.15. Southeast Asia Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
6.4.1.16. Rest of Asia Pacific Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
6.4.1.17. Rest of Asia Pacific Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
6.4.1.18. Rest of Asia Pacific Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
6.4.2. Market Attractiveness Analysis
7. Latin America Laboratory Developed Test Market Outlook, 2019 - 2031
7.1. Latin America Laboratory Developed Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2031
7.1.1. Key Highlights
7.1.1.1. Clinical Biochemistry
7.1.1.2. Critical Care
7.1.1.3. Haematology
7.1.1.4. Immunology
7.1.1.5. Microbiology
7.1.1.6. Molecular Diagnostics
7.1.1.7. Others
7.2. Latin America Laboratory Developed Test Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
7.2.1. Key Highlights
7.2.1.1. Oncology
7.2.1.2. Genetics
7.2.1.3. Infectious Diseases
7.2.1.4. Autoimmune Disorders
7.2.1.5. Neurology
7.3. Latin America Laboratory Developed Test Market Outlook, by End Use, Value (US$ Bn), 2019 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospital Laboratories
7.3.1.2. Specialty Diagnostics Centers
7.3.1.3. Clinical Research Organizations
7.3.1.4. Research Institutes
7.3.2. Market Attractiveness Analysis
7.4. Latin America Laboratory Developed Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
7.4.1.2. Brazil Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
7.4.1.3. Brazil Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
7.4.1.4. Mexico Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
7.4.1.5. Mexico Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
7.4.1.6. Mexico Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
7.4.1.7. Argentina Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
7.4.1.8. Argentina Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
7.4.1.9. Argentina Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
7.4.1.10. Rest of Latin America Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
7.4.1.11. Rest of Latin America Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
7.4.1.12. Rest of Latin America Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
7.4.2. Market Attractiveness Analysis
8. Middle East & Africa Laboratory Developed Test Market Outlook, 2019 - 2031
8.1. Middle East & Africa Laboratory Developed Test Market Outlook, by Test Type, Value (US$ Bn), 2019 - 2031
8.1.1. Key Highlights
8.1.1.1. Clinical Biochemistry
8.1.1.2. Critical Care
8.1.1.3. Haematology
8.1.1.4. Immunology
8.1.1.5. Microbiology
8.1.1.6. Molecular Diagnostics
8.1.1.7. Others
8.2. Middle East & Africa Laboratory Developed Test Market Outlook, by Application, Value (US$ Bn), 2019 - 2031
8.2.1. Key Highlights
8.2.1.1. Oncology
8.2.1.2. Genetics
8.2.1.3. Infectious Diseases
8.2.1.4. Autoimmune Disorders
8.2.1.5. Neurology
8.3. Middle East & Africa Laboratory Developed Test Market Outlook, by End Use, Value (US$ Bn), 2019 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospital Laboratories
8.3.1.2. Specialty Diagnostics Centers
8.3.1.3. Clinical Research Organizations
8.3.1.4. Research Institutes
8.3.2. Market Attractiveness Analysis
8.4. Middle East & Africa Laboratory Developed Test Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
8.4.1.2. GCC Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
8.4.1.3. GCC Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
8.4.1.4. South Africa Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
8.4.1.5. South Africa Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
8.4.1.6. South Africa Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
8.4.1.7. Egypt Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
8.4.1.8. Egypt Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
8.4.1.9. Egypt Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
8.4.1.10. Nigeria Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
8.4.1.11. Nigeria Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
8.4.1.12. Nigeria Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
8.4.1.13. Rest of Middle East & Africa Laboratory Developed Test Market by Test Type, Value (US$ Bn), 2019 - 2031
8.4.1.14. Rest of Middle East & Africa Laboratory Developed Test Market by Application, Value (US$ Bn), 2019 - 2031
8.4.1.15. Rest of Middle East & Africa Laboratory Developed Test Market by End Use, Value (US$ Bn), 2019 - 2031
8.4.2. Market Attractiveness Analysis
9. Competitive Landscape
9.1. By End User vs By Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Roche
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Adaptive Biotechnologies Corporation
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Quest Diagnostics
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Illumina
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Qiagen
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Eurofins
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Guardant Health
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Biotheranostics
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Rosetta Genomics
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Biodesix
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. 23andme, Inc.
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Admera Health
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Ambry Genetics Corp.
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Bruker Corporation
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. Epic Sciences, Inc.
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development
9.5.16. SCIEX Pte Ltd.
9.5.16.1. Company Overview
9.5.16.2. Product Portfolio
9.5.16.3. Financial Overview
9.5.16.4. 9.5.15.4. Business Strategies and Development
9.5.17. Opko Health, Inc./Opko Diagnostics
9.5.17.1. Company Overview
9.5.17.2. Product Portfolio
9.5.17.3. Financial Overview
9.5.17.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings